Comparing hemorrhagic risk in surgical abortions between 10 and 16 weeks
Voluntary Surgical Terminations of Pregnancy: Comparison of the Hemorrhagic Risk Depending on the Term, Between 10 and 14 Weeks of Amenorrhea or Between 14 and 16 Weeks of Amenorrhea
This study is trying to see if there’s a difference in bleeding risks during surgical abortions for women who are 10 to 16 weeks pregnant.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 168 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | University Hospital, Toulouse Academic / other |
| Locations | 1 site (Toulouse) |
| Trial ID | NCT06396338 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the hemorrhagic risk associated with voluntary surgical terminations of pregnancy performed between 10 and 16 weeks of gestation. It will involve women undergoing surgical abortion and will utilize questionnaires to gather data on complications and procedural differences based on the gestational term. The study is prompted by recent legislative changes in France that extended the legal period for abortion, highlighting the need for updated practice recommendations. The findings could provide valuable insights into the safety and risks of later-term surgical abortions.
Who should consider this trial
Good fit: Ideal candidates for this study are women undergoing surgical abortion between 10 and 16 weeks of gestation with a singleton pregnancy.
Not a fit: Patients who are under guardianship or have expressed refusal to participate will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve safety protocols and inform best practices for surgical abortions performed later in pregnancy.
How similar studies have performed: While there may be studies on surgical abortion risks, this specific comparison of hemorrhagic risk based on gestational term is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Woman treated for the performance of a surgical abortion between 10 and 16 weeks (dating by ultrasound) * Singleton pregnancy Exclusion Criteria: * Protected adult patient (guardianship, curatorship, safeguard of justice) * Refusal to participate expressed by the patient
Where this trial is running
Toulouse
- CHU Toulouse — Toulouse, France (Recruiting)
Study contacts
- Principal investigator: Lola LOUSSERT-CHAMBRE, MD — University Hospital, Toulouse
- Study coordinator: Caroline Peyrot, CRA
- Email: peyrot.c@chu-toulouse.fr
- Phone: 0561778486
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.